Drug
Vilanterol α-phenyl cinnamate clinical trials
Also written GW642444H.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses vilanterol α-phenyl cinnamate is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic PatientsCompletedPhase 1GlaxoSmithKlineNCT00463697Written as GW642444H (100mcg)
- A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.CompletedPhase 2GlaxoSmithKlineNCT00519376Written as GW642444H
- Study to Assess GW642444 in Asthma PatientsCompletedPhase 2GlaxoSmithKlineNCT00381667Written as GW642444H
Codes
What other systems call vilanterol α-phenyl cinnamate · ClinicalTrials.gg INT016319
- Wikidata Q27276316vilanterol α-phenyl cinnamateOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27276316 | vilanterol α-phenyl cinnamate | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.